C

Nephros, Inc. NEPH

$4.47 -$0.05-1.11% NASDAQ
Recommendation
Dividend Power Score
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
EPS (TTM)
Access our Premium Ratings
Get Access

Rating

Reward
Risk

Rating Factors

Growth Index
Efficiency Index
Solvency Index
Total Return Index
Volatility Index
Dividend Yield Index

Company Overview

Nephros, Inc. is a U.S.-based medical technology and water filtration company focused on products used in healthcare environments. The company operates primarily in the medical device and commercial water filtration industries, with business activities centered on infection prevention, dialysis-related technologies, and water purification systems designed for healthcare facilities. Its principal revenue drivers are ultrafilters used in hospitals and dialysis centers, along with legacy renal products associated with hemodiafiltration and fluid management applications.

The company evolved from an earlier focus on renal therapy and dialysis technologies into a broader healthcare water safety business. Over time, Nephros expanded its emphasis on water filtration systems intended to reduce exposure to waterborne pathogens in hospitals and clinical settings. Its positioning is tied to growing institutional attention on infection control, regulatory compliance, and water quality management in healthcare infrastructure. Public filings and company disclosures indicate that healthcare facilities, dialysis providers, and institutional customers represent core customer segments.

Data compiled by narrative technology. May contain errors.
Sector
Industry

Income Statement

Total Revenue (TTM)
EBITDA (TTM)
EBIT (TTM)
Net Income (TTM)

Balance Sheet

Total Assets (Q)
Total Debt (Q)
Total Liabilities (Q)
Book Value Per Share (Q)

Cash Flow

Cash from Operations (TTM)
Cash from Investing (TTM)
--
Cash from Financing (TTM)
Net Change in Cash (TTM)

Filings

Filing Date
Monday, August 10, 2026
Period Date
Tuesday, June 30, 2026
Next Filing
Week of Nov 2 and 6 (est)

Price History

Loading...
Beta
7-Day Total Return
30-Day Total Return
60-Day Total Return
90-Day Total Return
Year to Date Total Return
1-Year Total Return
2-Year Total Return
3-Year Total Return
5-Year Total Return
52-week Low
52-week High

Valuation

Market Cap
Enterprise Value
Price/Sales (TTM)
Price/Book (Q)

Dividends and Shares

Shares Outstanding
Dividend Per Share (Most Recent)
--
Dividend Per Share (TTM)
--

Corporate Info

Phone Number
201 343 5202
Address
380 Lackawanna Place
South Orange, NJ 07079
Country
Year Founded

Headlines

8/13/2026 - Nasdaq News: Markets
8/8/2026 - The Cerbat Gem
8/7/2026 - SeekingAlpha.com: All News
8/6/2026 - TipRanks: TheFly
5/11/2026 - The Cerbat Gem